The 10 Most Heavily Shorted Bio-Pharma Stocks

The 10 biotech and drug stocks with the largest short interest as percentage of float, according to S&P CapitalIQ:

10. Spectrum Pharmaceuticals (SPPI) (26.8% shares short)


^NBI Chart
^NBI data by YCharts

9. Dendreon (DNDN) (29.6% shares short)

DNDN Chart
DNDN data by YCharts

8. Achillion Pharma (ACHN) (29.7% shares short)


^NBI Chart
^NBI data by YCharts

7. Arena Pharmaceuticals (ARNA) (29.9% shares short)


ARNA Chart
ARNA data by YCharts

6. Ziopharm (ZIOP) (30.9% shares short)


ZIOP Chart
ZIOP data by YCharts

5. Intrexon (XON) (32.8% shares short)


XON Chart
XON data by YCharts

4. Idenix Pharma (IDIX) (33.3% shares short)


IDIX Chart
IDIX data by YCharts

3. Synta Pharma (SNTA) (36.4% shares short)


SNTA Chart
SNTA data by YCharts

2. Sarepta Therapeutics (SRPT) (39% shares short)


SRPT Chart
SRPT data by YCharts

1. Myriad Genetics (MYGN) (52.4% shares short)


MYGN Chart
MYGN data by YCharts

Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

More from Investing

7 Key Takeaways as Amazon Beats Estimates and Raises Prime's Price

7 Key Takeaways as Amazon Beats Estimates and Raises Prime's Price

Coke's a Better Stock to Buy Than Pepsi on Surprising North America Sales
Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Intel Stock Jumps After Earnings Beat, Raised Outlook for 2018

Intel Stock Jumps After Earnings Beat, Raised Outlook for 2018

Amazon Crushes Quarterly Earnings Estimates, Raises the Price of Prime

Amazon Crushes Quarterly Earnings Estimates, Raises the Price of Prime